Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications
Open accessThe DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
NAD(+) is a fundamental molecule in metabolism and redox signaling. In diabetes and its complications, the balance between NADH and NAD(+) can be severely perturbed. On one hand, NADH is overproduced due to influx of hyperglycemia to the glycolytic and Krebs cycle pathways and activation of the polyol pathway. On the other hand, NAD(+) can be diminished or depleted by overactivation of poly ADP ribose polymerase that uses NAD(+) as its substrate. Moreover, sirtuins, another class of enzymes that also use NAD(+) as their substrate for catalyzing protein deacetylation reactions, can also affect cellular content of NAD(+). Impairment of NAD(+) regeneration enzymes such as lactate dehydrogenase in erythrocytes and complex I in mitochondria can also contribute to NADH accumulation and NAD(+) deficiency. The consequence of NADH/NAD(+) redox imbalance is initially reductive stress that eventually leads to oxidative stress and oxidative damage to macromolecules, including DNA, lipids, and proteins. Accordingly, redox imbalance-triggered oxidative damage has been thought to be a major factor contributing to the development of diabetes and its complications. Future studies on restoring NADH/NAD(+) redox balance could provide further insights into design of novel antidiabetic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, NAD+ can be diminished or depleted by the overactivation of PARPs that uses NAD+ as their substrate for DNA repair.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [117]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This NAD+ /NADH ratio imbalance, also known as pseudohypoxia, initially causes reductive stress, mitochondrial overload, and dysfunction, which lead to oxidative stress and oxidative damage to macromolecules, including DNA, lipids, and proteins.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [117]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Accordingly, redox imbalance might be a major factor contributing to the development of diabetic complications [117].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [117]
The cited source says what the claim attributes to it.
In the citing paper
“The hallmark hyperglycemia of diabetes mellitus causes a redox imbalance between NAD+ and NADH ratio, which can lead to oxidative stress and a variety of metabolic syndromes.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Reactive oxygen species, cellular redox systems, and apoptosis
Circu, M. L., & Aw, T. Y. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.022 · Cited by 3,340 · cited 1×
“It has been reported that deacetylation by sirtuin protein can enhance NADPH production, which may be involved in restoring cellular redox balance.(78) Nonetheless, whether elevation of sirtuin levels in diabetes could restore or improve NADH/NAD+ redox balance needs to be further thoroughly investigated.”
Protein Oxidation in Aging, Disease, and Oxidative Stress
Berlett, B. S., & Stadtman, E. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20313 · Cited by 3,332
Stadtman, E. R. (1992) · Science · doi:10.1126/science.1355616 · Cited by 2,697
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Ying, W. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1672 · Cited by 1,494 · cited 1×
“of oxidized form of glutathione and further accentuation of redox imbalance.(13,55) As such, inhibition or deletion of aldose”
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Virág, L., & Szabó, C. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.375 · Cited by 1,373
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Role of Mitochondrial Dysfunction in Insulin Resistance
Kim, J.-A., Wei, Y., & Sowers, J. R. (2008) · Circulation Research · doi:10.1161/circresaha.107.165472 · Cited by 1,103
Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078
Stadtman, E. R. (2006) · Free Radical Research · doi:10.1080/10715760600918142 · Cited by 1,056
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899
Du, X., Matsumura, T., Edelstein, D., Rossetti, L., Zsengellér, Z., Szabó, C., & Brownlee, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18127 · Cited by 832 · cited 1×
“dihydrolipoamide dehydrogenase in the pyruvate dehydrogenase complex can be inhibited by NADH,(106,107) leading to potential reactive oxygen species (ROS) production.(82,108,109)”
Hirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M. M., Schwer, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.019 · Cited by 787 · cited 1×
“by sirtuins usually improve the function of the target proteins.(67) Therefore, sirtuins can be activated by starvation or caloric restriction to safeguard cell survival.”
The Sorbitol Pathway and the Complications of Diabetes
Steinmetz, P. R., Balko, C., & Gabbay, K. H. (1973) · New England Journal of Medicine · doi:10.1056/nejm197304192881609 · Cited by 759
Hirst, J. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-070511-103700 · Cited by 744
Helbock, H. J., Beckman, K. B., Shigenaga, M. K., Walter, P. B., Woodall, A. A., Yeo, H. C., & Ames, B. N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.288 · Cited by 692
Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going?
Hassa, P. O., Haenni, S. S., Elser, M., & Hottiger, M. O. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00040-05 · Cited by 682
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
Bridges, H. R., Jones, A. J. Y., Pollak, M. N., & Hirst, J. (2014) · Biochemical Journal · doi:10.1042/bj20140620 · Cited by 661
Protein Oxidation in Aging and Age‐Related Diseases
Stadtman, E. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05632.x · Cited by 660
The NAD metabolome — a key determinant of cancer cell biology
Chiarugi, A., Dölle, C., Felici, R., & Ziegler, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3340 · Cited by 639
Oxidative damage during aging targets mitochondrial aconitase
Yan, L.-J., Levine, R. L., & Sohal, R. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11168 · Cited by 620
Self-citationOxidative stress and the etiology of insulin resistance and type 2 diabetes
Henriksen, E. J., Diamond-Stanic, M. K., & Marchionne, E. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.005 · Cited by 600
Contributions of polyol pathway to oxidative stress in diabetic cataract
LEE, A. Y. W., & CHUNG, S. S. M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.23 · Cited by 533
Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5
Schlicker, C., Gertz, M., Papatheodorou, P., Kachholz, B., Becker, C. F. W., & Steegborn, C. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.048 · Cited by 531
Inactivation of specific β cell transcription factors in type 2 diabetes
Guo, S., Dai, C., Guo, M., Taylor, B., Harmon, J. S., Sander, M., Robertson, R. P., Powers, A. C., & Stein, R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65390 · Cited by 520
Bovine Complex I Is a Complex of 45 Different Subunits
Carroll, J., Fearnley, I. M., Skehel, J. M., Shannon, R. J., Hirst, J., & Walker, J. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607135200 · Cited by 487
Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease
Lin, S.-J., & Guarente, L. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00006-1 · Cited by 476
Jing, E., Emanuelli, B., Hirschey, M. D., Boucher, J., Lee, K. Y., Lombard, D., Verdin, E. M., & Kahn, C. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111308108 · Cited by 469
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
Aldose Reductase, Oxidative Stress, and Diabetic Mellitus
Tang, W. H., Martin, K. A., & Hwa, J. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00087 · Cited by 458
Streptozotocin–nicotinamide-induced diabetes in the rat. Characteristics of the experimental model
Szkudelski, T. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.011372 · Cited by 436
Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression
Santidrian, A. F., Matsuno-Yagi, A., Ritland, M., Seo, B. B., LeBoeuf, S. E., Gay, L. J., Yagi, T., & Felding-Habermann, B. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64264 · Cited by 433
Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
Yan, L.-J. (2014) · Journal of Diabetes Research · doi:10.1155/2014/137919 · Cited by 397 · cited 1×
“of oxidized form of glutathione and further accentuation of redox imbalance.(13,55) As such, inhibition or deletion of aldose”
Self-citationSeven sirtuins for seven deadly diseases ofaging
Morris, B. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.525 · Cited by 377
Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes
Dawson, T. L., Gores, G. J., Nieminen, A. L., Herman, B., & Lemasters, J. J. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.4.c961 · Cited by 346
NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
Cerutti, R., Pirinen, E., Lamperti, C., Marchet, S., Sauve, A. A., Li, W., Leoni, V., Schon, E. A., Dantzer, F., Auwerx, J., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.001 · Cited by 343
Aldose reductase and the role of the polyol pathway in diabetic nephropathy
Dunlop, M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07702.x · Cited by 334
Complex I deficiency: clinical features, biochemistry and molecular genetics
Fassone, E., & Rahman, S. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101159 · Cited by 320
The production of reactive oxygen species by complex I
Hirst, J., King, M. S., & Pryde, K. R. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360976 · Cited by 312
Quinlan, C. L., Goncalves, R. L. S., Hey-Mogensen, M., Yadava, N., Bunik, V. I., & Brand, M. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.545301 · Cited by 310 · cited 1×
“dihydrolipoamide dehydrogenase in the pyruvate dehydrogenase complex can be inhibited by NADH,(106,107) leading to potential reactive oxygen species (ROS) production.(82,108,109)”
Superoxide Is Produced by the Reduced Flavin in Mitochondrial Complex I
Pryde, K. R., & Hirst, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186841 · Cited by 302
de Kreutzenberg, S. V., Ceolotto, G., Papparella, I., Bortoluzzi, A., Semplicini, A., Man, C. D., Cobelli, C., Fadini, G. P., & Avogaro, A. (2010) · Diabetes · doi:10.2337/db09-1187 · Cited by 301
Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes
Pieper, A. A., Brat, D. J., Krug, D. K., Watkins, C. C., Gupta, A., Blackshaw, S., Verma, A., Wang, Z.-Q., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3059 · Cited by 298
Srivastava, R. A. K., Pinkosky, S. L., Filippov, S., Hanselman, J. C., Cramer, C. T., & Newton, R. S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r025882 · Cited by 296
Oxidants Are a Major Contributor to Aginga
AMES, B. N., & SHIGENAGA, M. K. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb38652.x · Cited by 292
Masutani, M., Suzuki, H., Kamada, N., Watanabe, M., Ueda, O., Nozaki, T., Jishage, K.-I., Watanabe, T., Sugimoto, T., Nakagama, H., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2301 · Cited by 286
Batandier, C., Guigas, B., Detaille, D., El-Mir, M., Fontaine, E., Rigoulet, M., & Leverve, X. M. (2006) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9003-8 · Cited by 279
Yan, L.-J., Christians, E. S., Liu, L., Xiao, X., Sohal, R. S., & Benjamin, I. J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf528 · Cited by 242
Self-citationObrosova, I. G., Drel, V. R., Pacher, P., Ilnytska, O., Wang, Z. Q., Stevens, M. J., & Yorek, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3435 · Cited by 231 · cited 1×
“The problem caused by activation of PARP in diabetes is that the enzyme is often overactivated, resulting in potential depletion of NAD+, which would further perturb NADH/NAD+ redox balance, leading to cell death.(21,79,84,85) PARP has been touted as a promising target for antidiabetic therapy.”
Yan, L.-J., & Wu, J. (2015) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s82272 · Cited by 223
Self-citationZheng, T., Yang, X., Wu, D., Xing, S., Bian, F., Li, W., Chi, J., Bai, X., Wu, G., Chen, X., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13120 · Cited by 221
Berg, D., Youdim, M. B. H., & Riederer, P. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0976-5 · Cited by 220
The human NAD metabolome: Functions, metabolism and compartmentalization
Nikiforov, A., Kulikova, V., & Ziegler, M. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1028612 · Cited by 215 · cited 1×
“their substrate are sirtuins and poly ADP ribose polymerases (PARPs).(27,61) As shown in Figure 3A, sirtuins use NAD+ for their deacetylation reactions, whereby NAD+ is degraded and nicotinamide and 2′-O-acetyl-ADP ribose are formed.”
Treberg, J. R., Quinlan, C. L., & Brand, M. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252502 · Cited by 212
Glucotoxicity and β-Cell Failure in Type 2 Diabetes Mellitus
Kaiser, Ν., Leibowitz, G., & Nesher, R. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.1.5 · Cited by 210
Du, X., Matsumura, T., Edelstein, D., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318127 · Cited by 200
Del Prato, S. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02847.x · Cited by 197
Karunakaran, U., & Park, K.-G. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.2.106 · Cited by 197
NAD + metabolism: A therapeutic target for age-related metabolic disease
Mouchiroud, L., Houtkooper, R. H., & Auwerx, J. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.789479 · Cited by 193
Oxidative Stress in Type 1 Diabetes
HASKINS, K., BRADLEY, B., POWERS, K., FADOK, V., FLORES, S., LING, X., PUGAZHENTHI, S., REUSCH, J., & KENCH, J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1288.006 · Cited by 190
Ethanol-induced oxidative stress: basic knowledge
Comporti, M., Signorini, C., Leoncini, S., Gardi, C., Ciccoli, L., Giardini, A., Vecchio, D., & Arezzini, B. (2010) · Genes & Nutrition · doi:10.1007/s12263-009-0159-9 · Cited by 188
Pacher, P., & Szabó, C. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1568 · Cited by 180 · cited 2×
“The problem caused by activation of PARP in diabetes is that the enzyme is often overactivated, resulting in potential depletion of NAD+, which would further perturb NADH/NAD+ redox balance, leading to cell death.(21,79,84,85) PARP has been touted as a promising target for antidiabetic therapy.”
Lefort, N., Glancy, B., Bowen, B., Willis, W. T., Bailowitz, Z., De Filippis, E. A., Brophy, C., Meyer, C., Højlund, K., Yi, Z., et al. (2010) · Diabetes · doi:10.2337/db10-0174 · Cited by 174
Recent Studies of Aldose Reductase Enzyme Inhibition for Diabetic Complications
Suzen, S., & Buyukbingol, E. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457377 · Cited by 171
NAD metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicity
Yang, T., & Sauve, A. A. (2006) · The AAPS Journal · doi:10.1208/aapsj080472 · Cited by 169
Human complex I defects in neurodegenerative diseases
Schapira, A. H. V. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00032-2 · Cited by 166
Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
Luo, X., Wu, J., Jing, S., & Yan, L. (2016) · Aging and Disease · doi:10.14336/ad.2015.0702 · Cited by 164
Self-citationSauve, A. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.01.021 · Cited by 161 · cited 1×
“Sirtuins are inducible enzymes.(62,63) Therefore, if NAD+ level Figure 1 Metabolic pathways and enzymes involved in NADH production using NAD+ as their cofactor.”
NAD+metabolism and oxidative stress: the golden nucleotide on a crown of thorns
Massudi, H., Grant, R., Guillemin, G. J., & Braidy, N. (2012) · Redox Report · doi:10.1179/1351000212y.0000000001 · Cited by 158 · cited 1×
“their substrate are sirtuins and poly ADP ribose polymerases (PARPs).(27,61) As shown in Figure 3A, sirtuins use NAD+ for their deacetylation reactions, whereby NAD+ is degraded and nicotinamide and 2′-O-acetyl-ADP ribose are formed.”
The regulation of glycolysis in mammalian erythrocytes.
Rapoport, S. M. (1968) · PubMed · Cited by 154
Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart
Anderson, E. J., Katunga, L. A., & Willis, M. S. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05641.x · Cited by 147
Niture, N. T., Ansari, A. A., & Suresh Ramnath, N. A. I. K. (2014) · PubMed · Cited by 146
Aldose Reductase in Diabetic Microvascular Complications
Chung, S. S. M., & Chung, S. S. M. (2005) · Current Drug Targets · doi:10.2174/1389450054021891 · Cited by 143
Assembly factors for the membrane arm of human complex I
Andrews, B., Carroll, J., Ding, S., Fearnley, I. M., & Walker, J. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319247110 · Cited by 136
Nitrosative Stress and Pathogenesis of Insulin Resistance
Kaneki, M., Shimizu, N., Yamada, D., & Chang, K. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1464 · Cited by 132
Raza, H., Prabu, S. K., John, A., & Avadhani, N. G. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12053133 · Cited by 132
Pharmacological Effects of Exogenous NAD on Mitochondrial Bioenergetics, DNA Repair, and Apoptosis
Pittelli, M. G., Felici, R., Pitozzi, V., Giovannelli, L., Bigagli, E., Cialdai, F., Romano, G., Moroni, F., & Chiarugi, A. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073916 · Cited by 132
Ying, W. (2007) · Frontiers in Bioscience · doi:10.2741/2267 · Cited by 122
Fritz, K. S., Galligan, J. J., Hirschey, M. D., Verdin, E., & Petersen, D. R. (2012) · Journal of Proteome Research · doi:10.1021/pr2008384 · Cited by 121
Parveen, K., Khan, M. R., Mujeeb, M., & Siddiqui, W. A. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.023 · Cited by 118
Basic Medical Biochemistry: A Clinical Approach
Marks, D. B., Marks, A. D., & Smith, C. M. (1996) · Cited by 117
Victor, V. M., Rocha, M., Bañuls, C., Sanchez-Serrano, M., Sola, E., Gomez, M., & Hernandez-Mijares, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0466 · Cited by 115
Stadler, K. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_21 · Cited by 114
Significance of fructose-induced protein oxidation and formation of advanced glycation end product
Takagi, Y., Kashiwagi, A., Tanaka, Y., Asahina, T., Kikkawa, R., & Shigeta, Y. (1995) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(94)00022-g · Cited by 113
Antoun, G., McMurray, F., Thrush, A. B., Patten, D. A., Peixoto, A. C., Slack, R. S., McPherson, R., Dent, R., & Harper, M.-E. (2015) · Diabetologia · doi:10.1007/s00125-015-3772-8 · Cited by 112
Mueller-Dieckmann, C., Kernstock, S., Lisurek, M., von Kries, J. P., Haag, F., Weiss, M. S., & Koch-Nolte, F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606762103 · Cited by 112 · cited 1×
“Another enzyme system that consumes and degrades NAD+ is PARPs, especially PARP-1(79) that can be activated by DNA damage.(22,80) As shown in Figure 3B, the products of PARP-catalyzed reaction are poly ADP ribosylated proteins and nicotinamide derived from NAD+.”
Marks Basic Medical Biochemistry, A Clinical Approach
Reviews, C. T. (2013) · Cited by 112
Regulation of Cell Survival and Death by Pyridine Nucleotides
Oka, S.-I., Hsu, C.-P., & Sadoshima, J. (2012) · Circulation Research · doi:10.1161/circresaha.111.247932 · Cited by 110
Exciting Times for Pancreatic Islets: Glutamate Signaling in Endocrine Cells
Otter, S., & Lammert, E. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.12.004 · Cited by 110
Huang, S., Yu, R.-T., Gong, J., Feng, Y., Dai, Y.-L., Hu, F., Hu, Y., Tao, Y.-D., & Leng, Y. (2011) · Diabetologia · doi:10.1007/s00125-011-2366-3 · Cited by 109
NAD and ADP‐ribose metabolism in mitochondria
Dölle, C., Rack, J. G. M., & Ziegler, M. (2013) · The FEBS Journal · doi:10.1111/febs.12304 · Cited by 108
Role of aldose reductase in the development of diabetes-associated complications
Kador, P. F., & Kinoshita, J. H. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90504-2 · Cited by 106
Methylglyoxal Induces Mitochondrial Dysfunction and Cell Death in Liver
Seo, K., Ki, S. H., & Shin, S. M. (2014) · Toxicological Research · doi:10.5487/tr.2014.30.3.193 · Cited by 106
Marks' Basic Medical Biochemistry: A Clinical Approach
Lieberman, M., Marks, A. D., & Chansky, M. (2008) · Medical University of Varna Repository · Cited by 104
Pyridine Nucleotide Regulation of Cardiac Intermediary Metabolism
Ussher, J. R., Jaswal, J. S., & Lopaschuk, G. D. (2012) · Circulation Research · doi:10.1161/circresaha.111.246371 · Cited by 98
Osmoregulation by slow changes in aldose reductase and rapid changes in sorbitol flux
Bagnasco, S. M., Murphy, H. R., Bedford, J. J., & Burg, M. B. (1988) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1988.254.6.c788 · Cited by 98
Prince, P. D., Lanzi, C. R., Toblli, J. E., Elesgaray, R., Oteiza, P. I., Fraga, C. G., & Galleano, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.009 · Cited by 95
Effects of pycnogenol treatment on oxidative stress in streptozotocin‐induced diabetic rats
Maritim, A. C., Dene, B. A., Sanders, R. A., & Watkins, J. B. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10078 · Cited by 94
Redox implications in adipose tissue (dys)function-A new look at old acquaintances
Jankovic, A., Korac, A., Buzadzic, B., Otasevic, V., Stancic, A., Daiber, A., & Korac, B. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.018 · Cited by 91 · cited 1×
“35,36 Under hyperglycemic conditions, both the glycolytic pathway and the Krebs cycle can be intensively fluxed by glucose.(37) Therefore, NADH can be overproduced in diabetes via these pathways,(38) and excess NADH is known to cause reductive stress.”
Glycolysis and pyruvate oxidation in cardiac hypertrophy—Why so unbalanced?
Leong, H. S., Brownsey, R. W., Kulpa, J. E., & Allard, M. F. (2003) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(03)00007-2 · Cited by 91
Luo, X., Li, R., & Yan, L. (2015) · Journal of Diabetes Research · doi:10.1155/2015/512618 · Cited by 90
Self-citationSirtuins as Possible Drug Targets in Type 2 Diabetes
Kitada, M., Kume, S., Kanasaki, K., Takeda‐Watanabe, A., & Koya, D. (2013) · Current Drug Targets · doi:10.2174/1389450111314060002 · Cited by 89 · cited 1×
“suggested as a therapeutic approach for treating diabetes and its complications.(71,72) It should be noted that among the seven members of the sirtuin family,(19,73) sirtuin 4 does not”
Genes, Diet and Type 2 Diabetes Mellitus: A Review
Dedoussis, G. V. Z., Kaliora, A. C., & Panagiotakos, D. B. (2007) · The Review of Diabetic Studies · doi:10.1900/rds.2007.4.13 · Cited by 86
Pyridine Nucleotide Redox Abnormalities in Diabetes
Ido, Y. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1630 · Cited by 84 · cited 3×
“Fatty acid β-oxidation fueling the production of acetyl-CoA can also be a significant source of NADH.(33) Additionally, glutamate dehydrogenase, a central enzyme involved in α-ketoglutarate formation from glutamate,(34) can also make NADH from NAD+.”
InfluentialHayden, M. R., & Tyagi, S. C. (2002) · PubMed · Cited by 83
Vedantham, S., Thiagarajan, D., Ananthakrishnan, R., Wang, L., Rosario, R., Zou, Y. S., Goldberg, I. J., Yan, S. F., Schmidt, A. M., & Ramasamy, R. (2013) · Diabetes · doi:10.2337/db13-0032 · Cited by 81 · cited 2×
“is low, sirtuin protein content would be low.(63,64) As acetylated proteins usually exhibit impaired functions,(65,66) deacetylation”
Sirt3 is essential for apelin‐induced angiogenesis in post‐myocardial infarction of diabetes
Hou, X., Zeng, H., He, X., & Chen, J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12453 · Cited by 80
Jaeschke, H., Kleinwaechter, C., & Wendel, A. (1992) · Chemico-Biological Interactions · doi:10.1016/0009-2797(92)90026-h · Cited by 78
The NAD ratio redox paradox: why does too much reductive power cause oxidative stress?
Teodoro, J. S., Rolo, A. P., & Palmeira, C. M. (2013) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.759305 · Cited by 75
Glucotoxicity and pancreatic proteomics
Brunner, Y., Schvartz, D., Priego‐Capote, F., Couté, Y., & Sanchez, J. (2008) · Journal of Proteomics · doi:10.1016/j.jprot.2008.10.002 · Cited by 74
Diabetes Induces Lysine Acetylation of Intermediary Metabolism Enzymes in the Kidney
Kosanam, H., Thai, K., Zhang, Y., Advani, A., Connelly, K. A., Diamandis, E. P., & Gilbert, R. E. (2014) · Diabetes · doi:10.2337/db12-1770 · Cited by 71
Caloric restriction: is mammalian life extension linked to p53?
Tucci, P. (2012) · Aging · doi:10.18632/aging.100481 · Cited by 71
Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy
Hodgkinson, A., Søndergaard, K. L., Yang, B., Cross, D. F., Millward, B. A., & Demaine, A. G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00788.x · Cited by 70
Papa, S., Sardanelli, A. M., Scacco, S., Petruzzella, V., Technikova-Dobrova, Z., Vergari, R., & Signorile, A. (2002) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1013863018115 · Cited by 67
Molecular Links between Caloric Restriction and Sir2/SIRT1 Activation
Wang, Y. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.5.321 · Cited by 66 · cited 1×
“Therefore, sirtuins can be activated by starvation or caloric restriction to safeguard cell survival.(68,69) On the other”
Sirtuins as novel players in the pathogenesis of diabetes mellitus
Turkmen, K. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.894 · Cited by 66 · cited 1×
“hand, overnutrition such as in diabetes that usually produces excess NADH with diminished NAD+ content can often lead to attenuation of sirtuin protein content.(20,70) Therefore,”
Aging: A shift from redox regulation to oxidative damage
Humphries, K. M., Szweda, P. A., & Szweda, L. I. (2006) · Free Radical Research · doi:10.1080/10715760600913184 · Cited by 65
Glutamate Dehydrogenase: Structure, Allosteric Regulation, and Role in Insulin Homeostasis
Li, M., Li, C., Allen, A., Stanley, C. A., & Smith, T. J. (2014) · Neurochemical Research · doi:10.1007/s11064-013-1173-2 · Cited by 65
Mouse HSF1 Disruption Perturbs Redox State and Increases Mitochondrial Oxidative Stress in Kidney
Yan, L.-J., Rajasekaran, N. S., Sathyanarayanan, S., & Benjamin, I. J. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.465 · Cited by 65
Self-citationYan, L., Yang, S., Shu, H., Prókai, L., & Forster, M. J. (2007) · Electrophoresis · doi:10.1002/elps.200600574 · Cited by 63 · cited 1×
“This is followed by pyruvate dehydrogenase complex that also makes NADH from NAD+, whereby the actual enzyme catalyzing NADH formation is dihydrolipoamide dehydrogenase.(31,32) After acetyl-CoA enters into the Krebs cycle, more molecules of NADH are produced, which can be ascribed to the action of isocitrate dehydroge…”
Self-citationMitochondrial complex I impairment in leukocytes from type 2 diabetic patients
Hernández‐Mijares, A., Rocha, M., Apostolova, N., Borrás, C., Jover, A., Bañuls, C., Solá, E., & Víctor, V. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.019 · Cited by 63
Obrosova, I., Minchenko, A., Frank, R., Seigel, G., Zsengeller, Z., Pacher, P., Stevens, M., & Szabó, C. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.14.1.55 · Cited by 61
Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1
Puthanveetil, P., Zhang, D., Wang, Y., Wang, F., Wan, A., Abrahani, A., & Rodrigues, B. B. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.08.013 · Cited by 61 · cited 1×
“The problem caused by activation of PARP in diabetes is that the enzyme is often overactivated, resulting in potential depletion of NAD+, which would further perturb NADH/NAD+ redox balance, leading to cell death.(21,79,84,85) PARP has been touted as a promising target for antidiabetic therapy.”
Erythrocyte mechanical fragility is increased in patients with type 2 diabetes
Lippi, G., Mercadanti, M., Aloe, R., & Targher, G. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.11.004 · Cited by 58 · cited 1×
“activity of LDH in red blood cells and in small platelets to handle NADH over-influx.(102,103) On the other hand, changes”
Deafblindness: a challenge for assessment-is the ICF a useful tool?
Möller, K. (2003) · International Journal of Audiology · doi:10.3109/14992020309074635 · Cited by 57
Jenkins, Y., Sun, T., Markovtsov, V. V., Foretz, M., Li, W., Nguyen, H. N., Li, Y., Pan, A., Uy, G., Groß, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081870 · Cited by 57
Tang, J., Du, Y., Petrash, J. M., Sheibani, N., & Kern, T. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062081 · Cited by 55
What comes first, misshape or dysfunction? The view from metabolic excess
Galloway, C. A., & Yoon, Y. (2012) · Journal of General Physiology · doi:10.1085/jgp.201210771 · Cited by 55
Targeting sirtuins for the treatment of diabetes
Huynh, F. K., Hershberger, K. A., & Hirschey, M. D. (2013) · Diabetes Management · doi:10.2217/dmt.13.6 · Cited by 52 · cited 1×
“suggested as a therapeutic approach for treating diabetes and its complications.(71,72) It should be noted that among the seven members of the sirtuin family,(19,73) sirtuin 4 does not”
Evidence in support of a concept of reductive stress
Lipiński, B. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2001435 · Cited by 52
Wilkinson, K. D., & Williams, C. H. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69779-6 · Cited by 51
Regulation and protection of mitochondrial physiology by sirtuins
Pereira, C. V., Lebiedzińska, M., Wieckowski, M. R., & Oliveira, P. J. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.07.003 · Cited by 51 · cited 2×
“It is probable that elevated levels of sirtuins alter the profiles of a given acetylated/deacetylated proteome, rendering metabolic pathways more efficient, which leads to more NADH utilization and thus more NAD+ regeneration.(74) It has been reported that deacetylation by sirtuin protein can enhance NADPH production,…”
Esposti, M. D., Ngo, A., & Myers, M. A. (1996) · Diabetes · doi:10.2337/diab.45.11.1531 · Cited by 49
Wu, J., Luo, X., & Yan, L.-J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00098 · Cited by 49 · cited 1×
“Nonetheless, it has been reported that complex I activity is decreased in diabetic skeletal muscles(104) but increased in diabetic kidneys.(105) Therefore, it seems that changes in complex I activity are tissue dependent in diabetic subjects.”
Self-citationYasunari, K., Kohno, M., Kano, H., Yokokawa, K., Horio, T., & Yoshikawa, J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2207 · Cited by 48
Yan, L., Thangthaeng, N., & Forster, M. J. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.01.006 · Cited by 48 · cited 1×
“This is followed by pyruvate dehydrogenase complex that also makes NADH from NAD+, whereby the actual enzyme catalyzing NADH formation is dihydrolipoamide dehydrogenase.(31,32) After acetyl-CoA enters into the Krebs cycle, more molecules of NADH are produced, which can be ascribed to the action of isocitrate dehydroge…”
Self-citationValadi, H., Valadi, Å., Ansell, R., Gustafsson, L., Adler, L., Norbeck, J., & Blomberg, A. (2003) · Current Genetics · doi:10.1007/s00294-003-0469-1 · Cited by 47
Horvath, E. M., Mágenheim, R., Kugler, E., Vácz, G., Szigethy, A., Lévárdi, F., Kollai, M., Szabó, C., & Lacza, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1435-3 · Cited by 46
Hotta, N. (1997) · PubMed · doi:10.18999/nagjms.60.3-4.89 · Cited by 45
Chiu, J., Xu, B. Y., Chen, S., Feng, B., & Chakrabarti, S. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-033 · Cited by 45
Yan, L., Lodge, J. K., Traber, M. G., & Packer, L. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9867 · Cited by 45
Self-citationLírio, L. M., Forechi, L., Zanardo, T. É. C., Batista, H. M., Meira, E. F., Nogueira, B. V., Mill, J. G., & Baldo, M. P. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.10.008 · Cited by 44 · cited 1×
“For example, sorbitol can accumulate in retinal and renal tissues and causes osmotic stress and cell death,(50,51) and fructose can cause nonenzymatic protein glycation or nitration(52,53) and contributes to pathogenesis of nonalcoholic fatty liver disease.(54) More importantly, a massive NADH production by this pathw…”
Rotenone induces reductive stress and triacylglycerol deposition in C2C12 cells
He, Q., Wang, M., Petucci, C., Gardell, S. J., & Han, X. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.09.011 · Cited by 44 · cited 1×
“Hence, it is imaginable that NADH oversupply could overwhelm LDH(100) or complex I.(101) Indeed, it has been”
Saini, A., Taliyan, R., & Sharma, P. (2014) · Pharmacognosy Magazine · doi:10.4103/0973-1296.131031 · Cited by 44
Inhibition of NADPH oxidase-1 preserves beta cell function
Weaver, J. R., Grzesik, W. J., & Taylor, D. (2014) · Diabetologia · doi:10.1007/s00125-014-3398-2 · Cited by 43
Human mitochondrial complex I dysfunction
Cooper, J. A. D., Mann, V. M., Krige, D., & Schapira, A. H. V. (1992) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(05)80019-2 · Cited by 41
Gallwitz, B., KAZDA, C. M., Kraus, P., Nicolay, C., & Schernthaner, G. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0319-4 · Cited by 39 · cited 1×
“level of glucose metabolism as glucose entry into the cells is not limited by insulin deficiency.(7,8) Since one of the major purposes of glucose metabolism is to provide”
Wu, J., & Yan, L. J. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 36
The Activity of Aldose Reductase Is Elevated in Diabetic Mouse Heart
Iwata, K., Nishinaka, T., Matsuno, K., Kakehi, T., Katsuyama, M., Ibi, M., & Yabe‐Nishimura, C. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070136 · Cited by 35
Byun, Y., Kang, B., Yoo, Y., & Joo, C. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16259 · Cited by 35
Fukaya, M., Tamura, Y., Chiba, Y., Tanioka, T., Mao, J., Inoue, Y., Yamada, M., Waeber, C., Ido-Kitamura, Y., Kitamura, T., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.024 · Cited by 34
Miwa, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-420-9 · Cited by 34
Boesten, D. M. P. H. J., von Ungern‐Sternberg, S. N. I., den Hartog, G. J. M., & Bast, A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/894597 · Cited by 32
Free fatty acid oxidation in insulin resistance and obesity.
Abel, E. D. (2010) · PubMed · Cited by 32
Robertson, R. P., Tanaka, Y., Takahashi, H., Tran, P. O. T., & Harmon, J. S. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.058 · Cited by 32
Aldose Reductase Inhibitor, Epalrestat, Reduces Lipid Hydroperoxides in Type 2 Diabetes
Ohmura, C., Watada, H., Azuma, K., Shimizu, T., Kanazawa, A., Ikeda, F., Yoshihara, T., Fujitani, Y., Hirose, T., Tanaka, Y., et al. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-237 · Cited by 31
Li, W. J., Zhou, J., Li, B., Wang, H., Peng, Y. B., & Wang, Z. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02176.x · Cited by 30 · cited 1×
“For example, 1,5-isoquinolinediol as a PARP inhibitor has been shown to improve corneal epithelial innervation in diabetic rats,(94) and PARP inhibition could improve erectile function in diabetic rodents.(95)”
Serum Dihydrolipoamide Dehydrogenase Is a Labile Enzyme.
Yan, L., Thangthaeng, N., Sumien, N., & Forster, M. J. (2013) · PubMed · Cited by 29
Self-citationHayden, M. R., & Sowers, J. R. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1640 · Cited by 28
Long, C. A., Boulom, V., Albadawi, H., Tsai, S. X., Yoo, H., Öklü, R., Goldman, M. H., & Watkins, M. T. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31828cced3 · Cited by 28
Yasunari, K., Kohno, M., Kano, H., Minami, M., & Yoshikawa, J. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1092 · Cited by 26
Hyperglycemic cytosolic reductive stress 'pseudohypoxia': implications for diabetic retinopathy.
Ido, Y., & Williamson, J. R. (1997) · PubMed · Cited by 25
Grape seed extract attenuates hyperglycaemia-induced in rats by streptozotocin
Awdan, S. A. E., Jaleel, G. A. A., & Saleh, D. O. (2013) · Bulletin of Faculty of Pharmacy Cairo University · doi:10.1016/j.bfopcu.2013.05.003 · Cited by 25
Sarras, M. P., Mason, S. M., McAllister, G., & Intine, R. V. A. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12216 · Cited by 24
Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Reddy, A. B. M., & Ramana, K. V. (2009) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/157489010790192683 · Cited by 21
Göhring, I., & Mulder, H. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0481 · Cited by 19
Acharya, J. D., Pande, A. J., Joshi, S. M., Yajnik, C. S., & Ghaskadbi, S. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2526 · Cited by 18
Esposti, M. D., Ngo, A., & Myers, M. A. (1996) · Diabetes · doi:10.2337/diabetes.45.11.1531 · Cited by 17
Diabetes Research: A Guide for Postgraduates
Tuch, B. E., Dunlop, M., & Proietto, J. (2000) · Medical Entomology and Zoology · Cited by 14
Lactate dehydrogenase activity of platelets in diabetes mellitus.
Zappacosta, B., Sole, P. D., Rossi, C. R., Marra, G., Ghirlanda, G., & Giardina, B. (1995) · PubMed · Cited by 10
Pathogenesis Of Chronic Complications Of Diabetes Mellitus
Teran, İ. O. (2021) · The Atlantic Journal of Medical Science and Research · doi:10.55358/atjmed.2021.8750 · Cited by 9
Nitrosative Stress and Pathogenesis of Insulin Resistance
Kaneki, M., Shimizu, N., Yamada, D., & Chang, K. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.ft-17 · Cited by 9
Valadi, H., Valadi, Å., Ansell, R., Gustafsson, L., Adler, L., Norbeck, J., & Blomberg, A. (2004) · Chalmers Publication Library (Chalmers University of Technology) · Cited by 1
Research works printed but not linked: 1
- [3]Barnett AH Type 2 Diabetes 2nd ed Oxford, UK Oxford University Press 2012
Cited by
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
The metabolic roots of senescence: mechanisms and opportunities for intervention
Wiley, C. D., & Campisi, J. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00483-8 · Cited by 691
Metabolic Responses to Reductive Stress
Xiao, W., & Loscalzo, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7803 · Cited by 462
Role of NAD+ in regulating cellular and metabolic signaling pathways
Amjad, S., Nisar, S., Bhat, A. A., Shah, A. R., Frenneaux, M. P., Fakhro, K., Haris, M., Reddy, R., Patay, Z., Baur, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101195 · Cited by 384
Redox imbalance stress in diabetes mellitus: Role of the polyol pathway
Yan, L. (2018) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12001 · Cited by 323
Self-citation
Metadata
- Authors
- Yan, L.-J., Wu, J., Jin, Z., & Zheng, H.
- Affiliations
- University of North Texas Health Science Center (US)
- Shandong University of Traditional Chinese Medicine (CN)
- Corresponding author
- Yan, Liang-Jun
- Venue
- Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2016-05
- Volume
- 9
- Pages
- 145
- ISSN
- 1178-7007 (ISSN-L)
- PMC
- PMC4869616
- OpenAlex
- W2363737748
- Cited by
- 198
- References
- 177
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 32 · 2023: 28 · 2022: 24 · 2021: 32 · 2020: 20 · 2019: 16 · 2018: 4 · 2017: 5 · 2016: 1
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diabetes Metabolic Syndrome and Obesity (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS079792)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Keywords
- diabetes complications, oxidative stress, reductive stress, polyol pathway, hyperglycemia, poly(ADP-ribose) polymerase, sirtuins, NAD+ regeneration, lactate dehydrogenase, complex I, oxidative DNA damage, oxidative lipid damage, protein oxidation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.